Your diarrhea is back. You’ve spotted blood in your poop. And you’re tired all the time. It could be an ulcerative colitis (UC) flare. Ask your doctor about biologic or biosimilar therapies for ...

Credit: Getty Images What have we learned in recent years about the safety and efficacy of different biologics for the treatment of ulcerative colitis? Ulcerative colitis (UC) is a condition with a ...

Please provide your email address to receive an email when new articles are posted on . Compared with placebo, most biologic and small molecule therapies correlated with superiority for the induction ...

Biologic therapy improves fatigue in patients with ulcerative colitis and Crohn's disease, with clinically meaningful changes observed within 6 months. Clinical remission is associated with an ...

Oral small-molecule therapies are redefining first-line treatment in moderate to severe ulcerative colitis (UC) by offering noninfusion alternatives with rapid onset and high efficacy. Etrasimod, a ...

Ulcerative colitis is a chronic, immune-mediated disorder of the colon, which is characterised by a relapsing–remitting course. Owing to the growing understanding of the immunopathogenesis of this ...

Week held in Berlin, Germany, an informative session explored emerging approaches for the management of ulcerative colitis (UC), ranging from surgical interventions to updated treatment guidelines and ...

Editor’s note: This is a previously posted video, and the below is an automatically generated transcript to be used for informational purposes. Please notify [email protected] if there are concerns ...

(MENAFN- EIN Presswire) EINPresswire/ -- According to DataM Intelligence, the ulcerative colitis treatment market size reached US$ 7.60 billion in 2023, increased to US$ 7.98 billion in 2024, and is ...